The Big Picture: David Becomes Goliath Imagine transforming from a small importer of medicines to becoming the world’s pharmacy – that’s India’s pharmaceutical story. In the 1950s, India could barely manufacture basic drugs. Today, it produces about 20% of the world’s generic medicines, supplies to over 200 countries, and houses some of the most sophisticated drug manufacturing facilities globally.
The Secret Sauce: How India Built Its Pharma Empire The transformation happened in four distinct stages, each like a crucial ingredient in a winning formula:
- The Foundation Years (1950s-60s)
- Think of a student learning from masters: India relied heavily on foreign companies
- Government acted like a protective parent, starting public sector companies
- Key players like IDPL and Hindustan Antibiotics were born
- The Game-Changing Move (1970s)
- The masterstroke: India’s Patent Act of 1970
- Like reverse engineering a recipe: Indian companies could now copy drug-making processes
- Result: Quality medicines at a fraction of global prices
- The Growth Spurt (1980s)
- Indian companies became self-reliant
- Started making everything from basic drugs to complex formulations
- Exports began flowing to other developing countries
- The Global Leap (1990s-present)
- Indian companies went from playing in local leagues to competing globally
- Focus shifted to innovation and research
- Companies started buying foreign firms and setting up global operations
The Present Picture: Strengths and Challenges
What’s Working:
- Among the fastest-growing pharma industries globally
- Produces 70% of domestic drug needs
- Generates consistent trade surpluses
- Houses world-class manufacturing facilities
The Growing Pains:
- Productivity lags behind global competitors
- R&D spending is still relatively low
- Market share in global exports remains around 1%
The New Playbook: How Indian Companies Are Going Global
- The Shopping Spree Strategy
- Companies like Ranbaxy, Dr. Reddy’s buying foreign firms
- Goal: Instant access to new markets and technologies
- The Partnership Path
- Contract manufacturing for global giants
- Research collaborations with international companies
- Marketing alliances in foreign markets
- The DIY Approach
- Setting up own subsidiaries abroad
- Building global distribution networks
- Developing new products for international markets
Looking Ahead: The Road Forward The paper suggests several key moves for India to strengthen its position:
- Encourage mergers among domestic companies to build scale
- Boost R&D spending
- Support overseas acquisitions
- Provide incentives for innovation
The Bottom Line India’s pharmaceutical industry has come a long way from its humble beginnings. While challenges remain, the sector has shown remarkable resilience and adaptability. With the right policies and strategies, it’s well-positioned to increase its global footprint further.
Academic Abstract:
What are the trends in the global competitiveness of the Indian pharmaceutical industry? Where does this industry stand when compared to global peers on pharmaceutical value‐added, productivity, research and development and trade performance? What are the new strategies that Indian pharmaceutical companies are adopting to become global players? These questions are addressed in this paper. It is found that strategic government policies were the main factors that transformed the status of the Indian pharmaceutical industry from a mere importer and distributor of drugs and pharmaceuticals to an innovation‐driven cost‐effective producer of quality drugs. India emerged as one of the fast growing pharmaceutical industry in the world with growing trade surpluses and exports. However, there are certain limitations that the government policies need to address, like low productivity and R&D intensity. A host of competitive strategies, like greenfield direct investment, overseas acquisitions, strategic alliances and contract manufacturing have emerged as favourites to Indian pharmaceutical firms recently.
Learn More:
Full citation: Pradhan, Jaya Prakash (2006), ‘Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies’, ISID Working Paper, No. WP2006/05, New Delhi: Institute for Studies in Industrial Development.
Learn More:
